The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity
about
Hypothalamic Obesity in Craniopharyngioma Patients: Disturbed Energy Homeostasis Related to Extent of Hypothalamic Damage and Its Implication for Obesity InterventionClues from bariatric surgery: reversing insulin resistance to heal the heartDo we really know why diabetes remits after gastric bypass surgery?Nutritional modulation of endogenous glucagon-like peptide-1 secretion: a reviewThe glucagon-like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodentsPharmacotherapy of Obesity: Clinical Trials to Clinical Practice.Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults.Development and validation of a rapid high-performance liquid chromatography method for the quantification of exenatide.Comparisons of weight changes between sodium-glucose cotransporter 2 inhibitors treatment and glucagon-like peptide-1 analogs treatment in type 2 diabetes patients: A meta-analysis.The effects of fiber enrichment of pasta and fat content on gastric emptying, GLP-1, glucose, and insulin responses to a meal.Breakfast frequency and quality may affect glycemia and appetite in adults and children.Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action.Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial.Weight loss effect of glucagon-like peptide-1 mimetics on obese/overweight adults without diabetes: A systematic review and meta-analysis of randomized controlled trials.The role of short chain fatty acids in appetite regulation and energy homeostasis.Effects of exenatide twice daily versus sitagliptin on 24-h glucose, glucoregulatory and hormonal measures: a randomized, double-blind, crossover study.Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes.Peripheral neural targets in obesityEndogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetesNewer therapeutic options for children with diabetes mellitus: theoretical and practical considerations.Gut-brain neuropeptides in the regulation of ingestive behaviors and obesity.Alterations in energy balance following exenatide administration.Glucose homeostasis and the gastrointestinal tract: insights into the treatment of diabetes.The Effects of Bariatric Procedures on Bowel HabitExposure-response analyses of liraglutide 3.0 mg for weight management.Treatment with sitagliptin or metformin does not increase body weight despite predicted reductions in urinary glucose excretion.Surgical weight loss: impact on energy expenditure.Is the GLP-1 system a viable therapeutic target for weight reduction?GLP-1 and energy balance: an integrated model of short-term and long-term controlDiabetes remission after bariatric surgery: is it just the incretins?GLP-1 based therapies: differential effects on fasting and postprandial glucose.Discovery and development of exenatide: the first antidiabetic agent to leverage the multiple benefits of the incretin hormone, GLP-1.Mechanisms and clinical efficacy of lixisenatide for the management of type 2 diabetes.The role of glucagon-like peptide-1 impairment in obesity and potential therapeutic implications.Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus.Therapies for inter-relating diabetes and obesity - GLP-1 and obesity.GLP-1: a mediator of the beneficial metabolic effects of bariatric surgery?The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases beta-cell mass in diabetic mice.A Systematic Review and Meta-analysis of the Effect of Gastric Bypass Surgery on Plasma Lipid Levels.Intestinal GLP-1 and satiation: from man to rodents and back.
P2860
Q26786921-D2FF777E-F8F7-4115-9056-2767F0643932Q26991653-E2AE03AF-CB00-4B47-A41B-AAD81F1D3118Q27026687-144F4A70-A068-45AC-B7DB-17F90F84A74AQ28070256-2D8B8CB8-860D-4E44-9892-F287839BAC3BQ28598004-7FD482CF-0254-47A7-BC5B-2817153FB39CQ30400748-D24A6DC8-066C-404D-B81D-0BFDF18CA2D0Q33570118-7ADC9CC5-6D8D-4EAB-92D8-DFEE9714156DQ33705580-63B02AC2-FD93-48DC-9C93-6351B0A4315AQ33871397-185D40A4-C926-434C-8728-C1CE93977E6DQ34175668-5DABA684-F5EB-4118-A816-0E5C78F3C8CEQ34402292-3625AB47-0D9F-4BA5-80A1-10036DEB0B63Q34503739-723FD95E-3E60-4E5A-9D23-5D65C4D8AF0EQ34566570-27EB29B5-9F67-4344-9808-22E70D0D1467Q35209811-804F924D-FC2F-4120-BA63-D8A44CDAFDE8Q35631071-120CFE5D-E8EF-460A-BD89-4C434C1B592FQ35673081-0487493B-32C7-45C3-AA52-195796734EA0Q35772029-B3B3CAFD-F4EA-404F-9CD4-F39AD16DEB57Q36166645-D36D42F0-4723-4FB0-9728-E2F035F3312BQ36240979-C0A10AF3-F295-48F0-8BD2-E0AC6DA60F32Q36455865-E9B090B0-36C0-4051-94BA-75CCB51AFE91Q36616593-30EAF27C-9CC8-4D62-9443-BB07E94606FDQ36758533-A60F91F9-35CA-44B7-B0B1-D1E6772A4865Q36816194-B7350ACC-CE2A-41F1-ADC1-E43CDB1C6BD5Q37245905-4DCE6BC1-744A-4165-9908-1A5B9E099A06Q37348898-C17ABB4D-78B2-4C55-8E63-2E55E14F5546Q37404353-C9A39603-D90C-443A-BF62-B7EDA81789E6Q37506168-00A5B53D-EFB2-448C-83E1-1E2CB5BD3F06Q37845218-3426E39B-2A97-411D-A345-CDD3FE650B5CQ37885717-323AD31C-C110-4171-BD27-99CB42266196Q37930945-4B66851E-6A74-431D-8E6E-2A4C224CE375Q37974712-9B076B53-F51C-43B9-BF9D-AC800CD737BDQ38066566-06F041F2-7284-4B50-9FCA-7A9612372E74Q38083047-886CCB4D-D371-4CFF-B722-74FBD7A1F667Q38101677-EBA33B6B-415E-421F-BF2D-7EEA4911BB51Q38174283-77916B91-41BE-4F2C-BDEF-8856E33C9863Q38254745-A98C01D2-CD42-4313-8C3E-482E667728BAQ38307449-4200F024-E272-4D52-BB35-54758E550485Q38363214-6FCE56DF-9F94-4935-B680-2AD428B52011Q38554099-A3A0B6CC-092C-49AC-8ACA-92B353CB50FEQ38575560-8B6840E9-D169-4F0C-833C-C423B0741D66
P2860
The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity
description
im Juni 2001 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 June 2001
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 2001
@uk
name
The effect of physiological le ...... ubstrate metabolism in obesity
@en
The effect of physiological le ...... ubstrate metabolism in obesity
@nl
type
label
The effect of physiological le ...... ubstrate metabolism in obesity
@en
The effect of physiological le ...... ubstrate metabolism in obesity
@nl
prefLabel
The effect of physiological le ...... ubstrate metabolism in obesity
@en
The effect of physiological le ...... ubstrate metabolism in obesity
@nl
P2093
P2860
P356
P1476
The effect of physiological le ...... ubstrate metabolism in obesity
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.IJO.0801627
P407
P577
2001-06-01T00:00:00Z